Perrigo's Zantac 150 Generic Marks First Approval From Remediated Plant
This article was originally published in The Tan Sheet
Perrigo will launch private-label equivalents of OTC heartburn reliever Zantac 150 this summer.
You may also be interested in...
Private label giant Perrigo is readying generic competitors to Reckitt Benckiser’s Mucinex and Takeda Pharmaceuticals’ Prevacid, CEO Joseph Papa says.
Perrigo's regulatory green light to market the first OTC generic of Men's Rogaine Foam further extends the pipeline that has kept the firm on a streak of record earnings.
Perrigo stokes momentum behind already healthy sales growth with significant steps in separate areas: a green light for regulatory compliance at its main manufacturing plant, and the launch of its generic OTC versions of Sanofi-Aventis' Allegra.